Perfromance Wealth Partners’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,000
Closed -$5.89K 195
2024
Q4
$5.89K Hold
11,000
﹤0.01% 185
2024
Q3
$19.4K Buy
+11,000
New +$19.4K ﹤0.01% 196